Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry

Journal of Chromatography B: Biomedical Applications

Volumn 685, Issue 2, 1996, Pages 251-263

  Blum, Wolfgang ^a   Faigle, Johann W ^b   Pfaar, Ulrike ^a   Sallmann, Alfred ^a  

^a CIBA GEIGY LTD   (Switzerland)

^b Ciba Geigy Ltd ^*  (Switzerland)

Author keywords

Diclofenac

Indexed keywords

DICLOFENAC; DRUG METABOLITE;

ADULT; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CONTROLLED STUDY; DERIVATIZATION; DRUG METABOLISM; DRUG URINE LEVEL; EXTRACTION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROLYSIS; HYDROXYLATION; INTERMETHOD COMPARISON; MALE; MASS SPECTROMETRY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; SUPERCRITICAL FLUID EXTRACTION; TECHNIQUE;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; ORGANOSILICON COMPOUNDS; TIME FACTORS; TRIFLUOROACETIC ACID;

EID: 0000534936     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(96)00198-3     Document Type: Article

References (29)

1. [1] H. Stierlin, J.W. Faigle, A. Sallmann, W. Küng, W.J. Richter, H.P. Kriemler, K.O. Alt and T. Winkler, Xenobiotica, 9 (1979) 601.
2. [2] W. Schneider and P.H. Degen, J. Chromatogr., 217 (1981) 263.
3. [3] W. Schneider and P.H. Degen, J. Chromatogr., 383 (1986) 412.
4. [4] J.W. Faigle, I. Böttcher, J. Godbillon, H.P. Kriemler, E. Schlumpf, W. Schneider, A. Schweizer, H. Stierlin and T. Winkler, Xenobiotica, 18 (1988) 1191.
5. [5] D. Lansdorp, T.J. Janssen, P.J.M. Guelen and T.B. Vree, J. Chromatogr., 528 (1990) 487.
6. [6] J. Godbillon, S. Gauron and J.P. Metayer, J. Chromatogr., 338 (1985) 151.
7. [7] G. Schmitz, H. Lepper and C.J. Estler, J. Chromatogr., 620 (1993) 158.
8. [8] R.J. Sawchuk, J.A. Maloney, L.L. Cartier, R.J. Rackley, K.K.H. Chan and H.S.L. Lau, Pharm. Res., 12 (1995) 756.
9. [9] A. Sioufi, F. Pommier and J. Godbillon, J. Chromatogr., 571 (1991) 87.
10. [10] H. Kadowaki, M. Shiino, I. Uemura and K. Kobayashi, J. Chromatogr., 308 (1984) 329.
11. [11] U.P. Geiger, P.H. Degen and A. Sioufi, J. Chromatogr., 111 (1975) 293.
12. [12] J.L. Kutschinki, Diss. Abstr. Int. B, 35 (1975) 4838.
13. [13] K.R. Kim, W.H. Shim, Y.J. Shin, J. Park, S. Myung and J. Hong, J. Chromatogr., 641 (1993) 319.
14. [14] P. Moser, A. Sallmann and I. Wiesenberg, J. Med. Chem., 33 (1990) 2358.
15. [15] W. Blum, K. Grolimund, P.E. Jordi and P. Ramstein, J. High Resol. Chromatogr. Chromatogr. Commun., 11 (1988) 441.
16. [16] W. Blum and R. Aichholz, J. Microcol. Sep., 5 (1993) 297.
17. [17] W. Blum, P. Ramstein and G. Eglinton, J. High Resol. Chromatogr. Chromatogr. Commun., 13 (1990) 85.
18. [18] A.L.C. Smit and F.H. Field, J. Am. Chem. Soc., 99 (1977) 6471.
19. [19] T.L. Chester, J.D. Pinkston and D.E. Raynie, Anal. Chem., 66 (1994) 106R.
20. [20] R.P. Evershed and J. Goad, Biomed. Environ. Mass Spectrom., 14 (1987) 131.
21. [21] T.A. Roy, F.M. Field, Y.Y. Lin and L.L. Smith, Anal. Chem., 51 (1979) 272.
22. [22] I. Wiesenberg-Boettcher, J. Pfeilschifter, A. Schweizer, A. Sallmann and P. Wenk, Agents Actions, 34 (1991) 135.
23. [23] A. Sallmann, personal communication.
24. [24] C.R. Creveling, N. Dalgard, H. Shimizu and J.W. Daly, Mol. Pharmacol., 6 (1970) 691.
25. [25] K. Korzekwa, W. Trager, M. Gouterman, D. Spangler and G.H. Loew, J. Am. Chem. Soc., 107 (1985) 4273.
26. [26] J.W. Faigle and K.F. Feldmann, in R.H. Levy, R.H. Mattson and B.S. Meldrum (Editors), Antiepileptic Drugs, Raven Press, New York, 4th ed., 1995, p. 499.
27. [27] R.E. Billings, Drug Metab. Dispos., 13 (1985) 287.
28. [28] T. Leemann, C. Transon and P. Dayer, Life Sci., 52 (1993) 29.
29. [29] B. Boudíková, C. Szumlanski, B. Maidak and R. Weinshilboum, Clin. Pharmacol. Ther., 48 (1990) 381.